USC.edu
Are You a Patient?

John M. Ringman, MD, MS

Professor of Clinical Neurology

Helene and Lou Galen Endowed Professorship in Neurology

Image of John M. Ringman, MD, MS
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Research Funding

  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · U01NS100614 · Sep 30, 2021 – Jul 31, 2026 · Role: Co-Principal Investigator
  • Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, Mexico
    NIH · R01AG069013 · Sep 15, 2020 – May 31, 2025 · Role: Principal Investigator
  • Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer?s Disease
    NIH · R01AG062007 · Feb 15, 2019 – Nov 30, 2024 · Role: Principal Investigator
  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · UF1NS100614 · Sep 30, 2016 – Jul 31, 2023 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH3NS100614 · Sep 30, 2016 – Jul 31, 2021 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH2NS100614 · Sep 30, 2016 – Jul 31, 2018 · Role: Co-Principal Investigator
  • The structural and functional connectome across Alzheimer's disease subtypes
    NIH · U01AG051218 · Sep 30, 2015 – Jun 30, 2021 · Role: Principal Investigator
  • Establishing Infrastructure for Prevention of familial AD in Mexico
    NIH · R21TW009787 · Sep 1, 2013 – Apr 30, 2018 · Role: Principal Investigator
  • FMRI in Pre-Symptomatic PS1-related Alzheimer's Disease
    NIH · K08AG022228 · Aug 1, 2003 – Jul 31, 2007 · Role: Principal Investigator
  • UCLA Alzheimer's Disease Research Center
    NIH · P50AG016570 · Apr 5, 1999 – Mar 31, 2016 · Role: Co-Principal Investigator

Publications

  • Safety considerations of gene-based therapies for Alzheimer’s disease. Alzheimers Dement. 2026 Jul; 22(7):e71515.. View in PubMed
  • Development and validation of a harmonized memory score for multicenter Alzheimer’s disease and related dementia research. Alzheimers Res Ther. 2026 Jun 15.. View in PubMed
  • Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers. Geroscience. 2026 Jun; 48(3):3649-3657.. View in PubMed
  • A novel mutation in colony-stimulating factor 1 receptor (CSF1R) causing CSF1R-related disorder (CSF1R-RD). Neurocase. 2026 Feb; 32(1):13-21.. View in PubMed
  • Graphical modeling of cortical tau pathology topography for its subtyping in Alzheimer’s disease. Imaging Neurosci (Camb). 2026; 4.. View in PubMed
  • Generative diffusion model enables quantification of calibration-free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer’s disease cohort. Alzheimers Dement (Amst). 2025 Oct-Dec; 17(4):e70214.. View in PubMed
  • The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease. Mol Neurodegener Adv. 2025; 1(1):4.. View in PubMed
  • GPU Accelerated Modeling of Cortical Radial and Tangential Connectivity Changes in Neurodegeneration. Med Image Comput Comput Assist Interv. 2026; 15971:342-351.. View in PubMed
  • MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics. Ann Neurol. 2026 02; 99(2):449-458.. View in PubMed
  • The relationship of soluble tau species with Alzheimer’s disease amyloid plaque removal and tau pathology. Alzheimers Dement. 2025 09; 21(9):e70689.. View in PubMed

Similar People